Pulse Biosciences EBITDA 2016-2024 | PLSE

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Pulse Biosciences ebitda from 2016 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Pulse Biosciences ebitda from 2016 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$213.1B
Intuitive Surgical (ISRG)	$180.3B
Alcon (ALC)	$45.3B
Edwards Lifesciences (EW)	$40.7B
IQVIA Holdings (IQV)	$38.1B
IDEXX Laboratories (IDXX)	$34.3B
DexCom (DXCM)	$27.5B
Waters (WAT)	$23B
STERIS (STE)	$22.2B
SONOVA HOLDING (SONVY)	$21.9B
Hologic (HOLX)	$19.1B
Fresenius Medical Care AG KGaA (FMS)	$11.6B
Sysmex ADR (SSMXY)	$11.5B
Globus Medical (GMED)	$10.1B
Teleflex (TFX)	$10B
Penumbra (PEN)	$9B
Masimo (MASI)	$7.7B
Glaukos (GKOS)	$7.2B
PROCEPT BioRobotics (PRCT)	$4.8B
Integer Holdings (ITGR)	$4.2B
Inari Medical (NARI)	$2.9B
LivaNova (LIVN)	$2.8B
TransMedics (TMDX)	$2.8B
Veracyte (VCYT)	$2.6B
Nihon Kohden (NHNKY)	$2.6B
Elekta AB (EKTAY)	$2.3B
Tandem Diabetes Care (TNDM)	$2.1B
RxSight (RXST)	$1.9B
Integra LifeSciences Holdings (IART)	$1.5B
Alphatec Holdings (ATEC)	$1.1B